Trial Profile
A Prospective Post Marketing Non Interventional Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive LHRH Analogues and to Evaluate the Effect of LHRH Analogues on Lower Urinary Tract Symptoms (ANALUTS Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms ANALUTS
- Sponsors Ipsen
- 27 Jul 2018 Status changed from active, no longer recruiting to completed.
- 27 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Sep 2015 New trial record